⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine EU February 23, 2024

Eldisine

📷 Wikipedia: Vindesine · Source
Eldisine
📷 Wikipedia: Vindesine · Source
INN
vindesine
Forms
Solution for injection
Strengths
5 mg
Area
Leukemia, Promyelocytic, Acute
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 931 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
1 days in total
May 20, 2026 May 21, 2026

What is this? Eldisine is a medicine given by injection. It contains the active substance vindesine. It is used to treat certain types of cancer.

What's happening? There is a shortage of Eldisine. Supplies may be limited for a time.

Does this affect me? If you or someone you care for uses Eldisine, talk to your doctor or pharmacist.

What should I do? Ask your pharmacist or doctor about other treatment options while Eldisine is in short supply.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
vindesine
Brand(s) / product name(s)
Eldisine
Agency-published detail

INN: vindesine · Forms: Solution for injection · Strengths: 5 mg · Area: Leukemia, Promyelocytic, Acute · Alternatives: Yes

First published
February 23, 2024
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
http://www.ema.europa.eu/en/medicines/human/shortages/eldisine

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Eldisine. INN: vindesine · Forms: Solution for injection · Strengths: 5 mg · Area: Leukemia, Promyelocytic, Acute · Alternatives: Yes
▸ When was this alert issued?
This alert was issued on February 23, 2024 by EMA (European Medicines Agency).
▸ Which countries are affected?
The alert applies to the entire EU.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.